Search filters

List of works by Ezia Bello

A biodistribution study of PEGylated PCL-based nanoparticles in C57BL/6 mice bearing B16/F10 melanoma.

scientific article

A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of action.

scientific article

A novel oral micellar fenretinide formulation with enhanced bioavailability and antitumour activity against multiple tumours from cancer stem cells

scientific article published on 22 August 2019

Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms.

scientific article published on 10 January 2017

Assessing the anti-tumour properties of Iraqi propolis in vitro and in vivo

scientific article published on 28 January 2012

Biological properties of IDN5174, a new synthetic camptothecin with the open lactone ring

scientific article published on November 2006

Chemical characterization of Iraqi propolis samples and assessing their antioxidant potentials

article

Clinical pharmacokinetics of the new oral camptothecin gimatecan: the inter-patient variability is related to alpha1-acid glycoprotein plasma levels.

scientific article published on 16 December 2009

Combination of PPARγ Agonist Pioglitazone and Trabectedin Induce Adipocyte Differentiation to Overcome Trabectedin Resistance in Myxoid Liposarcomas

scientific article published on 03 September 2019

Comparison of in vitro and in vivo biological effects of trabectedin, lurbinectedin (PM01183) and Zalypsis® (PM00104).

scientific article

Detection of tissue-specific effects by methotrexate on differentiating mouse embryonic stem cells

scientific article published in October 2004

E-3810 is a potent dual inhibitor of VEGFR and FGFR that exerts antitumor activity in multiple preclinical models

scientific article published on 6 January 2011

Establishment and characterisation of a new patient-derived model of myxoid liposarcoma with acquired resistance to trabectedin

scientific article published on 14 August 2019

Expression of thrombospondin-1 by tumor cells in patient-derived ovarian carcinoma xenografts.

scientific article published on 15 June 2015

HPLC-MS/MS method for quantitative determination of the novel dual inhibitor of FGF and VEGF receptors E-3810 in tumor tissues from xenograft mice and human biopsies.

scientific article

HPLC-MS/MS method to measure trabectedin in tumors: preliminary PK study in a mesothelioma xenograft model

scientific article published on August 2015

In Vitro and In Vivo Activity of Lucitanib in FGFR1/2 Amplified or Mutated Cancer Models.

scientific article published on 15 December 2016

Lurbinectedin reduces tumour-associated macrophages and the inflammatory tumour microenvironment in preclinical models

scientific article published on 6 July 2017

Mode of action of trabectedin in myxoid liposarcomas.

scientific article published on 11 November 2013

Novel models of myxoid liposarcoma xenografts mimicking the biological and pharmacologic features of human tumors.

scientific article published on 20 August 2010

PEGylated Nanoparticles Obtained through Emulsion Polymerization as Paclitaxel Carriers

scientific article published in December 2015

Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour.

scientific article published on 8 March 2017

Promising in vivo efficacy of the BET bromodomain inhibitor OTX015/MK-8628 in malignant pleural mesothelioma xenografts

scientific article published on 4 September 2016

Readily prepared biodegradable nanoparticles to formulate poorly water soluble drugs improving their pharmacological properties: The example of trabectedin

scientific article published on 7 March 2018

Self-Assembling PCL-Based Nanoparticles as PTX Solubility Enhancer Excipients

scientific article published on 25 July 2018

The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats

scientific article published on 30 October 2009

The tyrosine kinase inhibitor E-3810 combined with paclitaxel inhibits the growth of advanced-stage triple-negative breast cancer xenografts

scientific article

Paulina is supported by:

About Paulina

Help